OMA1-An Integral Membrane Protease?

Overview

Journal Biochim Biophys Acta Proteins Proteom

Publisher Elsevier

Specialties Biochemistry
Biophysics
Molecular Biology

Date 2020 Nov 1

PMID 33130089

Citations 12

Authors

Marcel V Alavi

Affiliations

Soon will be listed here.

Abstract

OMA1 is a mitochondrial protease. Among its substrates are DELE1, a signaling peptide, which can elicit the integrated stress response, as well as the membrane-shaping dynamin-related GTPase OPA1, which can drive mitochondrial outer membrane permeabilization. OMA1 is dormant under physiological conditions but rapidly activated upon mitochondrial stress, such as loss of membrane potential or excessive reactive oxygen species. Accordingly, OMA1 was found to be activated in a number of disease conditions, including cancer and neurodegeneration. OMA1 has a predicted transmembrane domain and is believed to be tethered to the mitochondrial inner membrane. Yet, its structure has not been resolved and its context-dependent regulation remains obscure. Here, I review the literature with focus on OMA1's biochemistry. I provide a good homology model of OMA1's active site with a root-mean-square deviation of 0.9 Å and a DALI Z-score of 19.8. And I build a case for OMA1 actually being an integral membrane protease based on OMA1's role in the generation of small signaling peptides, its functional overlap with PARL, and OMA1's homology with ZMPSTE24. The refined understanding of this important enzyme can help with the design of tool compounds and development of chemical probes in the future.

Citing Articles

Engineered bio-functional material-based nerve guide conduits for optic nerve regeneration: a view from the cellular perspective, challenges and the future outlook.

Obeng E, Shen B, Wang W, Xie Z, Zhang W, Li Z Regen Biomater. 2025; 12:rbae133.

PMID: 39776856 PMC: 11703557. DOI: 10.1093/rb/rbae133.

Mitochondrial membrane potential and oxidative stress interact to regulate Oma1-dependent processing of Opa1 and mitochondrial dynamics.

Fogo G, Raghunayakula S, Emaus K, Torres Torres F, Wider J, Sanderson T FASEB J. 2024; 38(18):e70066.

PMID: 39312414 PMC: 11542587. DOI: 10.1096/fj.202400313R.

Death-associated protein 3 in cancer-discrepant roles of DAP3 in tumours and molecular mechanisms.

Song H, Liu H, Wang X, Yang Y, Zhao X, Jiang W Front Oncol. 2024; 13:1323751.

PMID: 38352299 PMC: 10862491. DOI: 10.3389/fonc.2023.1323751.

Flt3 Activation Mitigates Mitochondrial Fragmentation and Heart Dysfunction through Rebalanced L-OPA1 Processing by Hindering the Interaction between Acetylated p53 and PHB2 in Cardiac Remodeling.

Zhang K, Zheng Y, Bao G, Ma W, Han B, Shi H Antioxidants (Basel). 2023; 12(9).

PMID: 37759959 PMC: 10525215. DOI: 10.3390/antiox12091657.

An OMA1 redox site controls mitochondrial homeostasis, sarcoma growth, and immunogenicity.

Miallot R, Millet V, Groult Y, Modelska A, Crescence L, Roulland S Life Sci Alliance. 2023; 6(6).

PMID: 37024121 PMC: 10078952. DOI: 10.26508/lsa.202201767.

References

Alavi M, Bette S, Schimpf S, Schuettauf F, Schraermeyer U, Wehrl H . A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy. Brain. 2007; 130(Pt 4):1029-42. DOI: 10.1093/brain/awm005. View

Ohba Y, MacVicar T, Langer T . Regulation of mitochondrial plasticity by the i-AAA protease YME1L. Biol Chem. 2020; 401(6-7):877-890. DOI: 10.1515/hsz-2020-0120. View

Dietz J, Bohovych I, Ponte Viana M, Khalimonchuk O . Proteolytic regulation of mitochondrial dynamics. Mitochondrion. 2019; 49:289-304. PMC: 6814530. DOI: 10.1016/j.mito.2019.04.008. View

Davies B, Fong L, Yang S, Coffinier C, Young S . The posttranslational processing of prelamin A and disease. Annu Rev Genomics Hum Genet. 2009; 10:153-74. PMC: 2846822. DOI: 10.1146/annurev-genom-082908-150150. View

Davies V, Hollins A, Piechota M, Yip W, Davies J, White K . Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum Mol Genet. 2007; 16(11):1307-18. DOI: 10.1093/hmg/ddm079. View

Tatsuta T, Model K, Langer T . Formation of membrane-bound ring complexes by prohibitins in mitochondria. Mol Biol Cell. 2004; 16(1):248-59. PMC: 539169. DOI: 10.1091/mbc.e04-09-0807. View

Cho S, Dickey S, Urban S . Crystal Structures and Inhibition Kinetics Reveal a Two-Stage Catalytic Mechanism with Drug Design Implications for Rhomboid Proteolysis. Mol Cell. 2016; 61(3):329-340. PMC: 4744120. DOI: 10.1016/j.molcel.2015.12.022. View

Korwitz A, Merkwirth C, Richter-Dennerlein R, Troder S, Sprenger H, Quiros P . Loss of OMA1 delays neurodegeneration by preventing stress-induced OPA1 processing in mitochondria. J Cell Biol. 2016; 212(2):157-66. PMC: 4738383. DOI: 10.1083/jcb.201507022. View

Wolfe M . Structure and Function of the γ-Secretase Complex. Biochemistry. 2019; 58(27):2953-2966. PMC: 6618299. DOI: 10.1021/acs.biochem.9b00401. View

10.

Quiros P, Ramsay A, Sala D, Fernandez-Vizarra E, Rodriguez F, Peinado J . Loss of mitochondrial protease OMA1 alters processing of the GTPase OPA1 and causes obesity and defective thermogenesis in mice. EMBO J. 2012; 31(9):2117-33. PMC: 3343468. DOI: 10.1038/emboj.2012.70. View

11.

Richter U, Lahtinen T, Marttinen P, Myohanen M, Greco D, Cannino G . A mitochondrial ribosomal and RNA decay pathway blocks cell proliferation. Curr Biol. 2013; 23(6):535-41. DOI: 10.1016/j.cub.2013.02.019. View

12.

Herkenne S, Ek O, Zamberlan M, Pellattiero A, Chergova M, Chivite I . Developmental and Tumor Angiogenesis Requires the Mitochondria-Shaping Protein Opa1. Cell Metab. 2020; 31(5):987-1003.e8. DOI: 10.1016/j.cmet.2020.04.007. View

13.

Caglayan S, Hashim A, Cieslar-Pobuda A, Jensen V, Behringer S, Talug B . Optic Atrophy 1 Controls Human Neuronal Development by Preventing Aberrant Nuclear DNA Methylation. iScience. 2020; 23(6):101154. PMC: 7251951. DOI: 10.1016/j.isci.2020.101154. View

14.

Spinazzi M, De Strooper B . PARL: The mitochondrial rhomboid protease. Semin Cell Dev Biol. 2016; 60:19-28. DOI: 10.1016/j.semcdb.2016.07.034. View

15.

Puchades C, Ding B, Song A, Wiseman R, Lander G, Glynn S . Unique Structural Features of the Mitochondrial AAA+ Protease AFG3L2 Reveal the Molecular Basis for Activity in Health and Disease. Mol Cell. 2019; 75(5):1073-1085.e6. PMC: 6731152. DOI: 10.1016/j.molcel.2019.06.016. View

16.

Griparic L, Kanazawa T, van der Bliek A . Regulation of the mitochondrial dynamin-like protein Opa1 by proteolytic cleavage. J Cell Biol. 2007; 178(5):757-64. PMC: 2064541. DOI: 10.1083/jcb.200704112. View

17.

McQuibban G, Lee J, Zheng L, Juusola M, Freeman M . Normal mitochondrial dynamics requires rhomboid-7 and affects Drosophila lifespan and neuronal function. Curr Biol. 2006; 16(10):982-9. DOI: 10.1016/j.cub.2006.03.062. View

18.

Del Dotto V, Fogazza M, Carelli V, Rugolo M, Zanna C . Eight human OPA1 isoforms, long and short: What are they for?. Biochim Biophys Acta Bioenerg. 2018; 1859(4):263-269. DOI: 10.1016/j.bbabio.2018.01.005. View

19.

Song Z, Chen H, Fiket M, Alexander C, Chan D . OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J Cell Biol. 2007; 178(5):749-55. PMC: 2064540. DOI: 10.1083/jcb.200704110. View

20.

Jin S, Lazarou M, Wang C, Kane L, Narendra D, Youle R . Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J Cell Biol. 2010; 191(5):933-42. PMC: 2995166. DOI: 10.1083/jcb.201008084. View